SI-BONE, Inc. (SIBN) Estados Financieros e Histórico

SI-BONE, Inc. (SIBN) — Precio $18.54 HealthcareMedical - Devices — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de SI-BONE, Inc. (SIBN): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

SI-BONE, Inc. registró ingresos de $200.9M en el último ejercicio fiscal, con un CAGR de 5 años del 22.3%.

Márgenes de los últimos 12 meses: margen bruto 79.5%, margen operativo -8.3%, margen neto -6.9%.

Al precio actual de $18.54, SIBN presenta beneficios negativos (P/E no significativo) y un ROE del -8.23%. La capitalización bursátil es de $822M.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$42.1M$48.0M$55.4M$67.3M$73.4M$90.2M$106.4M$138.9M$167.2M$200.9M
Coste de Ventas$5.2M$5.1M$4.8M$6.8M$8.9M$10.4M$15.7M$29.5M$35.1M$41.0M
Beneficio Bruto$36.9M$42.9M$50.5M$60.5M$64.5M$79.7M$90.7M$109.4M$132.1M$159.9M
I+D$6.4M$5.5M$5.4M$7.3M$9.5M$12.4M$13.6M$15.0M$16.6M$17.4M
Generales y Administrativos$48.1M$54.7M$57.1M$89.2M$93.6M$119.0M$136.7M$141.3M$150.8M$164.8M
Gastos Operativos$54.5M$60.2M$62.5M$96.5M$103.1M$131.4M$150.3M$156.4M$167.4M$182.2M
Beneficio Operativo-$17.6M-$17.4M-$12.0M-$36.0M-$38.6M-$51.7M-$59.6M-$46.9M-$35.2M-$22.3M
EBITDA-$16.2M-$15.8M-$11.6M-$32.7M-$36.5M-$51.0M-$55.0M-$34.4M-$23.1M-$10.9M
Gastos por Intereses$3.3M$6.2M$5.1M$4.9M$6.1M$5.4M$2.8M$3.5M$3.4M$5.3M
Beneficio Antes de Impuestos-$20.6M-$23.0M-$17.5M-$38.4M-$43.7M-$56.6M-$61.3M-$43.3M-$30.9M-$18.9M
Impuestos0000000000
Beneficio Neto-$20.6M-$23.0M-$17.5M-$38.4M-$43.7M-$56.6M-$61.3M-$43.3M-$30.9M-$18.9M
BPA$-1.33$-1.66$-1.10$-1.72$-1.50$-1.71$-1.79$-1.13$-0.75$-0.44
BPA Diluido$-1.33$-1.66$-1.10$-1.72$-1.50$-1.71$-1.79$-1.13$-0.75$-0.44
Acciones en Circulación (Diluidas)$15.5M$13.9M$15.9M$24.7M$29.1M$33.1M$34.2M$38.4M$41.5M$43.5M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$48.7M$56.4M$52.6M$56.0M
Beneficio Bruto$38.8M$44.5M$41.9M$44.5M
Beneficio Operativo-$5.4M-$2.5M-$5.1M-$4.8M
EBITDA-$2.4M$2.7M-$2.1M-$3.1M
Beneficio Neto-$4.6M-$1.6M-$4.3M-$4.1M
BPA$-0.11$-0.04$-0.10$-0.09
BPA Diluido$-0.11$-0.04$-0.10$-0.09

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$27.9M$22.4M$25.1M$10.4M$53.6M$63.4M$20.7M$33.3M$34.9M$42.2M
Inversiones a Corto00$97.1M$81.3M$142.9M$83.6M$76.6M$132.7M$115.1M$105.6M
Cuentas por Cobrar$6.0M$7.4M$8.5M$11.7M$13.6M$14.2M$20.7M$22.0M$27.5M$29.9M
Inventario$1.5M$2.6M$3.3M$5.5M$5.6M$11.5M$17.3M$20.2M$27.1M$33.9M
Activos Corrientes$36.3M$33.6M$136.0M$111.5M$218.2M$175.9M$137.6M$211.4M$207.8M$216.1M
Inmovilizado Material$2.6M$1.9M$2.2M$4.0M$4.5M$14.2M$19.6M$18.7M$22.4M$22.4M
Fondo de Comercio0000000000
Activos Intangibles$47000$7.4M00000000
Activos Totales$39.4M$35.8M$138.5M$117.0M$223.1M$190.5M$157.6M$230.4M$230.4M$238.6M
Cuentas por Pagar$1.0M$1.8M$2.1M$2.8M$3.3M$3.2M$6.3M$4.6M$6.5M$4.6M
Deuda a Corto$8.2M00$4.4M00000$944000
Pasivos Corrientes$13.4M$7.5M$9.0M$18.8M$13.5M$16.9M$21.2M$23.5M$27.1M$25.3M
Deuda a Largo$21.1M$38.7M$39.0M$34.9M$39.5M$35.0M$35.2M$36.1M$35.5M$175000
Pasivos Totales$148.2M$165.2M$48.3M$54.0M$53.8M$56.1M$59.2M$61.0M$63.5M$61.0M
Reservas-$116.7M-$139.7M-$157.2M-$195.6M-$239.3M-$295.8M-$357.1M-$400.4M-$431.4M-$450.3M
Patrimonio Neto-$108.7M-$129.4M$90.2M$63.0M$169.4M$134.4M$98.3M$169.4M$167.0M$177.5M
Deuda Total$29.3M$38.7M$39.0M$39.2M$39.5M$40.5M$39.4M$39.0M$37.5M$1.1M
Deuda Neta$1.4M$16.3M-$83.3M-$52.6M-$157.0M-$106.5M-$57.9M-$127.0M-$112.6M-$146.7M
Capital Circulante$22.9M$26.1M$127.0M$92.7M$204.8M$159.0M$116.4M$187.9M$180.6M$190.8M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$26.5M$42.2M$33.5M$33.1M
Activos Totales$234.3M$238.6M$242.7M$248.8M
Pasivos Totales$62.1M$61.0M$63.8M$66.4M
Patrimonio Neto$172.1M$177.5M$178.9M$182.3M
Deuda Total$36.8M$1.1M$7.3M$7.2M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$20.6M-$23.0M-$17.5M-$38.4M-$43.7M-$56.6M-$61.3M-$43.3M-$30.9M-$18.9M
Amortizaciones$1.0M$1.0M$722000$774000$1.1M$2.1M$3.5M$5.4M$4.4M$2.7M
Compensación en Acciones$1.4M$1.4M$2.3M$7.5M$11.9M$16.9M$23.1M$24.1M$25.9M$25.5M
Cambio en Capital Circulante-$198000$382000-$1.0M-$479000-$2.5M-$5.8M-$7.6M-$4.8M-$10.1M-$14.3M
Flujo de Caja Operativo-$16.8M-$17.5M-$14.5M-$31.6M-$30.7M-$39.5M-$41.7M-$18.7M-$12.4M-$675000
Inversiones (CapEx)-$441000-$478000-$942000-$2.4M-$2.6M-$6.4M-$9.5M-$7.8M-$10.5M-$8.4M
Adquisiciones00000-$58.0M0000
Recompra de Acciones-$30000-$730000000000
Dividendos Pagados0000000000
Flujo de Caja Libre-$17.2M-$18.0M-$15.5M-$34.1M-$33.2M-$45.9M-$51.2M-$26.5M-$22.9M-$9.1M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo$2.3M$1.7M-$2.4M$777000
Inversiones (CapEx)-$3.0M-$1.3M-$1.1M-$1.5M
Flujo de Caja Libre-$620000$440000-$3.4M-$768000
Dividendos Pagados0000
Compensación en Acciones$6.2M$6.0M$6.0M$6.0M

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)+14.0%+15.4%+21.5%+9.0%+22.8%+18.0%+30.5%+20.4%+20.2%
Crecimiento Beneficio Neto (anual)-11.9%+24.2%-120.0%-13.8%-29.5%-8.3%+29.3%+28.7%+38.8%
Crecimiento BPA (anual)-24.8%+33.7%-56.4%+12.8%-14.0%-4.7%+36.9%+33.6%+41.3%
Cambio en Acciones (anual)-10.4%+14.7%+55.4%+17.6%+14.1%+3.2%+12.4%+7.9%+4.9%
Crecimiento FCF (anual)-4.7%+14.1%-120.4%+2.5%-38.2%-11.4%+48.2%+13.5%+60.3%
Margen Bruto87.7%89.3%91.3%89.9%87.9%88.4%85.2%78.8%79.0%79.6%
Margen Operativo-41.7%-36.2%-21.6%-53.5%-52.6%-57.3%-56.0%-33.8%-21.1%-11.1%
Margen EBITDA-38.6%-33.0%-21.0%-48.6%-49.7%-56.5%-51.7%-24.8%-13.8%-5.4%
Margen Neto-48.9%-48.0%-31.5%-57.1%-59.5%-62.8%-57.6%-31.2%-18.5%-9.4%
Margen FCF-40.8%-37.5%-27.9%-50.6%-45.3%-50.9%-48.1%-19.1%-13.7%-4.5%
Tasa Impositiva Efectiva-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-1.11$-1.30$-0.97$-1.38$-1.14$-1.39$-1.50$-0.69$-0.55$-0.21
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$15.5M$13.9M$15.9M$24.7M$29.1M$33.1M$34.2M$38.4M$41.5M$43.5M

Qué mirar en Salud / Farma

El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.

Rentabilidad

Rentabilidad sobre capital-8.23%
Rentabilidad sobre capital invertido-7.88%
Rentabilidad sobre activos-5.88%
Margen bruto79.53%
Margen operativo-8.31%
Margen neto-6.85%

Salud financiera

Deuda / Patrimonio0.04
Ratio corriente9.15
Piotroski F-Score6
Altman Z-Score7.29

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-15.08-12.08-18.99-12.50-19.93-12.99-7.60-18.58-18.69-44.82
P/VC-2.86-2.153.688.435.135.484.734.763.484.83
P/V7.385.806.007.8911.848.174.375.813.484.27
Margen Bruto87.7%89.3%91.3%89.9%87.9%88.4%85.2%78.8%79.0%79.6%
Margen Operativo-41.7%-36.2%-21.6%-53.5%-52.6%-57.3%-56.0%-33.8%-21.1%-11.1%
Margen Neto-48.9%-48.0%-31.5%-57.1%-59.5%-62.8%-57.6%-31.2%-18.5%-9.4%

Empresas relacionadas: AIRS · AQST · AVNS · AVXL · BFLY · CLPT · INNV

Explorar sector: Healthcare · Medical - Devices

Más secciones de SIBN: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones